Evidence map›Paper›PMID 37942470›Full record

ArticleJAMIA open2023

Creation of a data commons for substance misuse related health research through privacy-preserving patient record linkage between hospitals and state agencies.

Majid Afshar, Madeline Oguss, Thomas A Callaci, Timothy Gruenloh, Preeti Gupta, Claire Sun, Askar Safipour Afshar, Joseph Cavanaugh, Matthew M Churpek, Edwin Nyakoe-Nyasani and 8 more

Open access · goldAbstract read
In one paragraph

Article in JAMIA open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Majid AfsharSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.ORCID https://orcid.org/0000-0002-6368-4652
Madeline OgussSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
Thomas A CallaciSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
Timothy GruenlohSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
Preeti GuptaDivision of Pulmonary and Critical Care, University of Illinois-Chicago, Chicago, IL 60607, United States.
Claire SunSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
Askar Safipour AfsharSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
Joseph CavanaughSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
Matthew M ChurpekSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
Edwin Nyakoe-NyasaniState of Wisconsin Department of Health Services, Madison, WI 53703, United States.
Huong Nguyen-HilfigerState of Wisconsin Department of Health Services, Madison, WI 53703, United States.
Ryan WestergaardSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
Elizabeth Salisbury-AfsharSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
Megan GussickSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
Brian PattersonSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.ORCID https://orcid.org/0000-0002-4584-3808
Claire MannehDatavant Incorporated, San Francisco, CA 94104, United States.
Jomol MathewSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
Anoop MayampurathSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, United States.
University of Wisconsin–Madison · USWisconsin Department of Health Services · USRoivant Sciences (United States) · USUniversity of Illinois Chicago · US

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
Data Driven Strategies for Substance Misuse Identification in Hospitalized PatientsR01DA051464 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI Majid Afshar · 2020 to 2026
$4.5M
Postdoctoral Training Program in Pulmonary and Critical Care Translational ResearchT32HL144909 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEK, STEVEN M, FINN, PATRICIA W · 2019 to 2023
$1.3M
Using Machine Learning to Predict Clinical Deterioration in Hospitalized ChildrenK01HL148390 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI MAYAMPURATH, ANOOP · 2019 to 2023
$738k
NCATS NIH HHS UL1 TR002373NHLBI NIH HHS K01 HL148390NHLBI NIH HHS T32 HL144909NIDA NIH HHS R01 DA051464
6 · The paper itself

Abstract

Objectives: Substance misuse is a complex and heterogeneous set of conditions associated with high mortality and regional/demographic variations. Existing data systems are siloed and have been ineffective in curtailing the substance misuse epidemic. Therefore, we aimed to build a novel informatics platform, the Substance Misuse Data Commons (SMDC), by integrating multiple data modalities to provide a unified record of information crucial to improving outcomes in substance misuse patients. Materials and Methods: The SMDC was created by linking electronic health record (EHR) data from adult cases of substance (alcohol, opioid, nonopioid drug) misuse at the University of Wisconsin hospitals to socioeconomic and state agency data. To ensure private and secure data exchange, Privacy-Preserving Record Linkage (PPRL) and Honest Broker services were utilized. The overlap in mortality reporting among the EHR, state Vital Statistics, and a commercial national data source was assessed. Results: The SMDC included data from 36 522 patients experiencing 62 594 healthcare encounters. Over half of patients were linked to the statewide ambulance database and prescription drug monitoring program. Chronic diseases accounted for most underlying causes of death, while drug-related overdoses constituted 8%. Our analysis of mortality revealed a 49.1% overlap across the 3 data sources. Nonoverlapping deaths were associated with poor socioeconomic indicators. Discussion: Through PPRL, the SMDC enabled the longitudinal integration of multimodal data. Combining death data from local, state, and national sources enhanced mortality tracking and exposed disparities. Conclusion: The SMDC provides a comprehensive resource for clinical providers and policymakers to inform interventions targeting substance misuse-related hospitalizations, overdoses, and death.

Indexed as

alcoholdata commonshealth information exchangeopioidssubstance abuse

Identifiers

PMID37942470
PMCPMC10629613
OpenAlexW4388452318

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.